{"schema_version":"secwatch.filing_event.v1","accession":"0001393052-22-000022","form_type":"8-K","ticker":"VEEV","cik":"0001393052","company_name":"VEEVA SYSTEMS INC","filed_at":"2022-06-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.452429+00:00","generated_at":"2026-06-25T05:24:31.588953+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Veeva Q1 revenue $505.1M (+16% YoY); non-GAAP EPS $0.99 vs $0.91","bullets":["Total revenues $505.1M, up 16% YoY; subscription services $402.6M, up 18% YoY.","GAAP net income $100.1M ($0.62 diluted EPS); non-GAAP net income $159.8M ($0.99 EPS).","Crossed $2B annual revenue run rate; non-GAAP operating income up 10% YoY to $199.6M.","Top 20 pharma adopted 12 Development Cloud products; >350 customers have 2+ apps.","Management cites 15% penetration in $7B R&D TAM, sees long growth runway."],"urls":{"canonical":"https://secwatch.observer/filing/0001393052-22-000022","json":"https://secwatch.observer/filing/0001393052-22-000022.json","markdown":"https://secwatch.observer/filing/0001393052-22-000022.md","text":"https://secwatch.observer/filing/0001393052-22-000022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1393052/000139305222000022/0001393052-22-000022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1393052/000139305222000022/veev-20220601.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:24:31.588953+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}